Pure Global

Qualitative test for IgG or complement binding to red blood cells - Vietnam Registration 2402952ĐKLH/BYT-HTTB

Access comprehensive regulatory information for Qualitative test for IgG or complement binding to red blood cells in Vietnam's medical device market through Pure Global AI's free database. This Risk Class TTBYT Loại C medical device is registered under number 2402952ĐKLH/BYT-HTTB and manufactured by Ortho-Clinical Diagnostics, Inc.. The authorized representative in Vietnam is CÔNG TY CỔ PHẦN THIẾT BỊ SISC VIỆT NAM.

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 300,000+ Vietnamese medical device registrations, helping global MedTech companies navigate Vietnam MOH regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
300,000+ Devices
2402952ĐKLH/BYT-HTTB
Registration Details
Vietnam MOH Registration: 2402952ĐKLH/BYT-HTTB
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

Qualitative test for IgG or complement binding to red blood cells
VN: Thuốc thử xét nghiệm định tính IgG hoặc bổ thể liên kết với tế bào hồng cầu
Risk Class TTBYT Loại C

Registration Details

2402952ĐKLH/BYT-HTTB

000.00.04.G18-230825-0027

Anti-IgG, -C3d; polyspecific BioCIone® (Green)

716122

Company Information

UNITED STATES

Ortho-Clinical Diagnostics

Technical Details

Used in in vitro qualitative testing to detect IgG or complement bound to red blood cells.

Dates and Status

Oct 22, 2024